Medication Guidelines for Chronic Heart Failure due to Reduced Ejection Fraction (HF-REF) (pdf)
Medication Guidelines for Chronic Heart Failure due to Reduced Ejection Fraction (HF-REF)
Posted in cardiology, pharmacy, policy and tagged Ace inhibitor, Beta-blocker, Cardiology, Chronic Heart Failure, Diuretic Management, Eplerenone, Heart failure, Ivabradine, Mineralocorticoid antagonist, Reduced Ejection Fraction, Sacubitril, Spironolactone, Systolic Dysfunction, Valsartan.
Last updated: June 15, 2017